CME CirclePrint this Activity for Offline ReferenceInstructions on Taking Medscape CME

Management of Mycoses: Expanding Therapeutic Options CME
Chairperson: John E. Bennett, MD; Faculty: Elias J. Anaissie, MD; Ben E. de Pauw, MD, PhD; Pamela A. Lipsett, MD; Kent A. Sepkowitz, MD
Disclosures

Release Date: November 20, 2003; Valid for credit through November 20, 2004

This activity has expired.
CME in this activity indicates that it was developed according to ACCME guidelines and was certified for credit by one or more accredited CME or CE providers. Medscape cannot attest to the timeliness of expired CME activities.


This CME activity is based on transcripts and slides of presentations as delivered by the faculty at the "Management of Mycoses: Expanding Therapeutic Options" symposium held at the Lakeside Center in Chicago, Illinois on September 14, 2003.

Contents of This CME Activity
This program is offered in two formats. Please choose one of the versions:

    Flash Version
    (A multimedia presentation with synchronized audio, slides and transcript.)
    Note: Macromedia's Flash Player 5 plug-in is required to view the Flash version.
    Download the Macromedia Flash Player 5 plug-In:

    Get Flash 5

    --OR--

    Slides with transcript and RealAudio:

  1. Diagnosis and Management of Fusariosis
    by Elias Anaissie, MD
    Fusariosis: An Overview
    Pathogenesis
    Diagnosis and Prognosis
    Prevention and Treatment

  2. Preemptive Antifungal Therapy
    by Ben E. de Pauw, MD, PhD
    Introduction
    Introduction, cont'd
    Recognizing the Risk Factors
    Colonization -- Invasion
    Who Is at Risk?
    Who Is at Risk?, cont'd
    Response to Treatment
    Empirical Antifungal Therapy

  3. Candidiasis in the Intensive Care Unit
    by Pamela A. Lipsett, MD
    Fungal Infections in the Intensive Care Unit
    Epidemiology and Risk
    Outcome and Economic Impact
    Issues and Approaches to Infection
    Risks of Peritonitis
    In Support of Prophylaxis
    Fluconazole and Selective Digestive Decontamination
    Prophylaxis and Infection
    Answers and More Questions

  4. Antifungal Prophylaxis in the Neutropenic and HSCT Patient
    by Kent A. Sepkowitz, MD
    Antifungal Prophylaxis: Definitions and Questions
    Looking at the Research
    Itraconazole, Fluconazole, and Other Drugs
    Meta-Analyses
    Answers and Conclusions

These educational activities, certified by accredited providers, were not prepared by Medscape's editors, but are made available on our site as a service to our audience. Authors are routinely instructed by the provider to disclose significant financial relationships and mention of investigational drugs and unapproved indications. Medscape has received a fee for posting these activities. Direct questions or comments to: CME@webmd.net.

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape, The Academy for Healthcare Education, the companies providing educational grants or the authors and writers. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. All readers and continuing education participants should verify all information and consult a qualified healthcare professional before treating patients or utilizing any therapeutic product discussed in this educational activity.

 
Copyright © 2003 the Academy for Healthcare Education.
Pfizer
  • This activity has expired.

    The accredited provider can no longer issue certificates for this activity. Medscape cannot attest to the timeliness of expired CME activities.

  • CME Information
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.